Online Prescriptions

Online Prescriptions - Click Here
HomeAlpha IndexCategories

Bookmark and Share

Prescriptions : A

Prescriptions : B

Prescriptions : C

Prescriptions : D

Prescriptions : E

Prescriptions : F

Prescriptions : G

Prescriptions : H

Prescriptions : I

Prescriptions : J

Prescriptions : K

Prescriptions : L

Prescriptions : M

Prescriptions : N

Prescriptions : O

Prescriptions : P

Prescriptions : Q

Prescriptions : R

Prescriptions : S

Prescriptions : T

Prescriptions : U

Prescriptions : V

Prescriptions : W

Prescriptions : X

Prescriptions : Y

Prescriptions : Z

Prescriptions : 0-9

Home

Product Index

Category List

Acomplia (Rimonabant)

Home » Weight Loss » Acomplia (Rimonabant)

Diet pill Acomplia (Rimonabant) is a miraculous multifunctional pill that helps you short out obesity as well as smoking. Acomplia diet pills work on the Endocannabinoid system which controls appetite and energy expenditure (as well as the urge to smoke). This wonder pill selectively blocks some receptors in the Endocannabinoid system thus creating a better balance which in turn suppresses appetite and the longing to overeat.

Buy Acomplia (Rimonabant) and other Weight Loss products online at Medstore.

Buy Online at Medstore - Click Here!

About Acomplia (Rimonabant):

Product Type: Weight Loss

Brand name: Acomplia Generic name: Rimonabant What is Acomplia? • Acomplia (rimonabant) is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1). • Acomplia is used in the treatment of obesity and related conditions. How does Acomplia work? • Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism including adipose tissue the liver gastrointestinal tract and muscle1. • Acomplia switches off the same brain circuits that make people hungry when they smoke cannabis. • CB1 receptor blockade with Acomplia acts to decrease the overactivity of the endocannabinoid system (EC system)2 3. The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance as well as glucose and lipid (or fat) metabolism. What is Acomplia used for? • Acomplia is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. • Sanofi argues that Acomplia can also prevent the risk of cardiovascular disease. • Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the drug. Does Acomplia also aid smoking cessation? • Acomplia has been studied by sanofi-aventis as an aid to smoking cessation based on studies for up to one year in over 6 500 smokers motivated to quit smoking. • Sanofi-aventis submitted a New Drug Application to the FDA which in turn issued a non approvable letter for Acomplia for use in smoking cessation. An approvable letter was however issued for Acomplia for use in weight management. Acomplia has just been approved in the European Union. Is Acomplia approved in the United States? • No. Sanofi is still awaiting U.S. marketing go-ahead which it has said could come by the end of this year. • U.S. health authorities have asked Sanofi for more information on Acomplia. • Acomplia received European Union marketing approval in June 2006. • The first launch will take place in Britain in July and be followed by launches in Denmark Ireland Germany Finland and Norway in the second half of this year according to Sanofi. What were the results of Acomplia Clinical trial studies? • In clinical studies Acomplia has been shown to improve a wide array of cardiometabolic risk factors as well as promoting sustained weight loss4 5. • Approximately half of the observed improvement in HDL-cholesterol triglycerides and HbA1C (an indicator of blood sugar control) in patients who received Acomplia 20mg was beyond that expected from weight loss alone6. What are the side-effects of Acomplia? • Side effects in the trial on Acomplia in obesity were vomiting and nausea forcing about 19 percent of patients to leave the trial versus 13 percent of those who took placebo.

Generic Acomplia (Rimonabant)

Slimona

20mg 120 pills 20mg 240 pills 20mg 60 pills 20mg 30 pills 20mg 90 pills Rimonabant Acomplia

View more Weight Loss

Previous Product  Next Product

Online Prescriptions.
 
Industry News : Marquette General Health System joins Premier healthcare alliance. Marquette General Health System of Marquette, Mich., has joined the Premier healthcare alliance, consisting of more than 2,500 hospitals and 76,000 other healthcare sites, to improve care delivery. “We believe this new partnership will help improve the value of the health services Marquette provides to our community and look forward to furthering our work with Premier.” As a Premier owner, Marquette leverages a national purchasing network delivering industry-leading contract pricing. The not-for-profit health system formerly utilized MedAssets as its national purchasing organization. Marquette also collaborates and compares performance with other members of the alliance to improve care efficiency while safely reducing waste and costs using the nation's largest clinical, financial and operational database. "Premier's business model is unique in that it is completely owned by its members and thus accountable to and fully aligned with their goals," said Gary Muller, president & CEO at Marquette. "We believe this new partnership will help improve the value of the health services Marquette provides to our community and look forward to furthering our work with Premier." The health system participates in two Premier collaboratives for additional performance improvement opportunities. As a new member of Premier's ASCEND® (Accelerated Supply Chain Endeavor) program, Marquette aggregates, monitors and analyzes supply chain data to identify improvement opportunities. This includes simplified and consistent purchasing processes, appropriate clinical utilization and specially negotiated contracts. Members of ASCEND have saved $56 million over two years, without sacrificing the quality of care. To support its purchasing decisions, the health system uses Premier supply chain tools like SpendAdvisor® MySpend™, to easily examine spend data.
 
MACLAR Klacid 
Macrobid (Nitrofurantoin) 
Macrodantin (Nitrofurantoin Macrocystals) 
MADOPAR Prolopa 
Malirid Generic Primaquine 
Marvelon Desogestrel Ethinyl Oestradiol 
Maxalt (Rizatriptan) 
Maximune Invirase 
Maxolon Clopra 
Maxolon (Metoclopramide) 
MEBEX Vermox 
Medrol Deltastab 
MEFTAL Ponstel 
Melalite Forte Cream Aclaro 
Melanocyl Uvadex 
MELOSET MEL 
Memantine NAMENDA 
M Enalapril Generic Renitec 
Meprate Modus 
MESACOL Asacol 
Metaspray Nasonex 
Metformin Generic Glucophage 
Methotrexate 
Methycobal Generic Mecobalamin 
Metocard XL Toprol XR 
METOLAR Betaloc 
METOLAR H Selopres 
Metpamid Reglan